Global Burden of Cancer, 2010 to 2019
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6987?guestAccessKey=de848f90-c09a-4361-9e2a-fe2c6562d9a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=123021
JAMAONCO_OF:12232021
Visual Abstract: Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 23, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5981?guestAccessKey=f7d45c3d-a78d-4435-a89c-fb8eb9afa57d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122321 Visual Abstract Authors:…
JAMAONCO_OF:12162021
JAMAONCO_OF:12092021
Diversity Among US Radiation, Medical Oncology Faculty
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 9, 2021 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6011?guestAccessKey=bb9a9220-1bbf-4ab2-96f9-b077e4984ff8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120921 What The Study Did: The results of…
JAMAONCO_OF:12022021
Effectiveness of COVID-19 Vaccination in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 2, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5771?guestAccessKey=5fcd8b60-734c-4f79-8c52-139d4f069eac&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120221 What The Study Did: In this study of Veterans…
JAMAONCO_OF:11242021
Association Between Neighborhood Socioeconomic Inequality, Cervical Cancer Rates in New York City
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5779?guestAccessKey=875a08ed-82ac-42d8-befe-cd94de00c5cd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: In this population-based, cross-sectional study, researchers…
Eligibility of Black Women Under USPSTF Lung Cancer Screening Guidelines
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5790?guestAccessKey=988b5b64-a314-4333-ab42-05e8abd58fe2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: Researchers evaluated lung cancer screening eligibility…
Change in COVID-19 Mortality in Patients With Cancer During Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6199?guestAccessKey=34bfddf6-8dcb-4cc5-b112-3792eda89ee4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: Evolving outcomes of COVID-19 in patients…
Outcomes of Screening for Prostate Cancer Among Men Who Use Statins
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5672?guestAccessKey=b34f9b8a-3809-4044-9079-510749446219&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421
JAMAONCO_OF:11232021
Assessing Response to Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Patients With Solid Tumors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6764?guestAccessKey=fa2f67e0-5398-479e-9c84-040b27818f41&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112321
JAMAONCO_OF:11182021
Telemedicine Use by Socioeconomic Status Among Patients With Newly Diagnosed Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5784?guestAccessKey=1bebfa23-1ea5-41a2-ab62-02ba8f55f0b5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821 What The Study Did: Researchers found that among 16,000…
Visual Abstract: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5445?guestAccessKey=9e2e2632-3143-4a5a-bff7-c19a1983fea5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821 Visual Abstract Authors:…
T-Cell Responses to SARS-CoV-2 Vaccines in Patients With B-Cell Depletion
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6030?guestAccessKey=d5abc9d4-27a3-4f58-bb04-59ee7ca15a4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821
JAMAONCO_11112021
Progress Against Cancer Deaths 50 Years After National Cancer Act Passed
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 11, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5668?guestAccessKey=fa22406b-0c85-463b-a38f-8a0bcd08f48f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111121 What The Study Did: This year is the 50th anniversary…
JAMAONCO_OF:11042021
JAMAONCO_OF:10282021
COVID-19 Death, Adverse Outcomes in Patients With, Without Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 28, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5148?guestAccessKey=f51f92f4-9ae3-44f9-a1b1-659a3d763658&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102821 What The Study Did: In this study of more than…
JAMAONCO_OF:10252021
Visual Abstract: Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 5:05 P.M. (ET), MONDAY, OCTOBER 25, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6036?guestAccessKey=fccdc560-4934-481d-954a-55b6eb373e97&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102521 Visual Abstract Authors: Chang-Ok…
JAMAONCO_OF:10212021
JAMAONCO_OF:10142021
Visual Abstract: Fulvestrant-Palbociclib vs. Letrozole-Palbociclib as Initial Therapy for Advanced Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 7, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4301?guestAccessKey=4c8d31e5-75de-4219-ac23-dc4434ce706d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100721 Visual Abstract Authors:…
JAMAONCO_OF:10072021
JAMAONCO_OF:09302021
Visual Abstract: Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 23, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3836?guestAccessKey=a7dff299-41e1-42da-b547-14b4adaf1c37&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092321 Visual Abstract Authors:…
JAMAONCO_OF:09232021
JAMAONCO_OF:09162021
JAMAONCO_OF:09092021
Changes in Life Expectancy After Allogeneic Blood or Marrow Transplantation
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 9, 2021 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3676?guestAccessKey=3f852df3-f991-471c-82a1-43005d1ca1a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090921 What the Study Did: Researchers examined changes…
JAMAONCO_OF:09022021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4083?guestAccessKey=401c5452-3b52-469f-9933-a9d18759821c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2907?guestAccessKey=3cf1521e-cf5a-47b4-bc5c-dcb87818f64e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221
Visual Abstract: Ensartinib vs Crizotinib for Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 2, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3523?guestAccessKey=7cd645db-d6d0-45a4-9410-6c64a6b47b0c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221 Visual Abstract…
JAMAONCO_OF:08292021
JAMAONCO_OF:08262021
Visual Abstract: Effect of Cisplatin, Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 26, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3441?guestAccessKey=52eb480f-85bb-4d72-a750-c6e4ea579e7a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082621 Visual Abstract Authors:…
Visual Abstract: Effectiveness of Adding Everolimus to First-line Treatment of Advanced Breast Cancer in Premenopausal Women
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 26, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3428?guestAccessKey=6fff4c46-c0eb-49ef-b0f8-67ce316f4a8d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082621 Visual Abstract Authors:…
JAMAONCO_08192021
Targeted COVID-19 Vaccine Outreach to Marginalized Populations
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 19, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3833?guestAccessKey=e97a3e2d-c47b-4e45-8c0f-d7e191421467&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921 What The Study Did: Researchers at the North Carolina Cancer…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3585?guestAccessKey=cf61110c-09cd-4a01-9041-e0e1412ada0a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921
Visual Abstract: Effects of Exercise on Prostate Cancer Under Active Surveillance
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 19, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3067?guestAccessKey=b71e6940-300a-4fae-b55d-470ef7e132ca&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921 Visual Abstract…
JAMAONCO_OF:08122021
Visual Abstract: Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 12, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3186?guestAccessKey=a1568e25-3f53-4723-affc-0c54defb0aa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081221 Visual Abstract…
JAMAONCO_OF:08112021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4381?guestAccessKey=e21e391b-70b8-42e8-a852-5a369db2c2f4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081121
Durability of Response to SARS-CoV-2 BioNTech-Pfizer Vaccination in Patients on Active Anticancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 11, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/2783031?guestAccessKey=2e3b178f-9053-43ef-9178-298837b421a7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081121 What The Study Did: Researchers describe the antispike IgG antibody…
JAMAONCO_OF:08052021
Visual Abstract: Chemoradiotherapy With S-1 for Older Patients With Esophageal Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 5, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2705?guestAccessKey=1faeb082-838d-4047-865d-058634208242&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080521 Visual Abstract…
Visual Abstract: Metformin With Chemoradiotherapy Outcomes in Locally Advanced Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 29, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2328?guestAccessKey=1e018809-7b94-4606-9e5b-c6d9b7407f33&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072921 Visual Abstract…
JAMAONCO_OF:07292021
Visual Abstract: Comparing Chemoradiation Plus Metformin vs Chemoradiation for Stage III Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 29, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2318?guestAccessKey=d6c68b4c-6e50-4804-b5e2-69f923758f70&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072921 Visual Abstract…
JAMAONCO_OF:07222021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3127?guestAccessKey=0e0076cb-82fb-4273-ab82-bcf0ecb5431f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221
Prostate Cancer Treatment Among Black, White Patients During Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 22, 2021 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2755?guestAccessKey=bd1d5058-6861-4ca9-9126-aec996c6ba22&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221 What The Study Did: This study included…
Visual Abstract: Treatment of High-risk Medulloblastoma in Children
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 22, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2224?guestAccessKey=12dbd65b-1312-4066-ab73-41b4830c1581&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221 Visual Abstract…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2582?guestAccessKey=8a0dd195-672e-4a08-b3b4-3144408c2b25&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221
JAMAONCO_OF:07152021
Effect of Celecoxib on Survival Among Patients With Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 15, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2193?guestAccessKey=3ea1cbd0-f72c-46a2-b041-313a26c9cde9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071521 Visual Abstract…
Nivolumab Plus Ipilimumab for Advanced Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 15, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2209?guestAccessKey=19094b6b-dc8e-4aa5-aa5e-9f8f7587be76&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071521 Visual Abstract Authors:…
JAMAONCO_OF:07082021
Pfizer-BioNTech Vaccine in Patients Undergoing Cancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 8, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2675?guestAccessKey=a006b52c-6abf-414d-b0b9-b57946450d20&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070821 What The Study Did: The SARS-CoV-2 BNT162b2 (Pfizer-BioNTech) vaccine…
JAMAONCO_OF:07012021
JAMAONCO_OF:06242021
Survival Outcomes of Breast Cancer Patients Receiving 5 Years vs 2 Years of Bisphosphonate
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 24, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1854?guestAccessKey=959725dd-dae7-4cfb-99ed-4fe21347f8a0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062421 Visual Abstract …
JAMAONCO_OF:06172021
Association of Convalescent Plasma Therapy With Survival in Patients With Blood Cancers, COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 17, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1799?guestAccessKey=4030509c-d734-45ca-919e-6d5974537caa&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061721 What The Study Did: Researchers evaluated the association of…
JAMAONCO_OF:06102021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1794?guestAccessKey=ef411da1-823b-4a94-b6b8-852b9b886f36&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061021
COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 10, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1962?guestAccessKey=8716f8b1-300f-49b4-be0c-ee2d9ff191a6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061021 What The Study Did: This survey study among women…
JAMAONCO_OF:06042021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1499?guestAccessKey=d6c7b910-c310-4af9-8ce5-9992e344d13f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060421
JAMAONCO_OF:06032021
JAMAONCO_OF:05282021
Seropositivity Following mRNA Vaccination for SARS-CoV-2 in Patients Undergoing Cancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MAY 28, 2021 Media advisory: The full article and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2155?guestAccessKey=41cd3cc4-ce5f-4607-9680-86c094b38c0a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=053121 What The Study Did: Rates of antispike…
SARS-CoV-2 Antibody Status in Patients With Cancer, Health Care Workers
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MAY 28, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2159?guestAccessKey=8aeadda1-2dff-4136-9127-a1ac36668722&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=053121 What The Study Did: This study evaluates whether there…
JAMAONCO_OF:05272021
JAMAONCO_OF:05202021
JAMAONCO_OF:05132021
COVID-19 Vaccines in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 13, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1218?guestAccessKey=deb70871-d54c-413f-a354-affb2bd968e5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051321 What The Viewpoint Says: Questions regarding the safety of…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1254?guestAccessKey=843ee507-b75d-4009-bc2a-0db067d319a8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051321
JAMAONCO_OF:05062021
JAMAONCO_OF:04292021
Association of Cancer Screening Decline With COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 29, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0884?guestAccessKey=2e43ed34-0a44-4101-9dae-319f9a2c065c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042921 What The Study Did: Using insurance claims data, the…
Efficacy, Safety of Carboplatin vs Carboplatin Plus Paclitaxel for Older Women With Ovarian Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 22, 2021 Media advisory: The full article and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0696?guestAccessKey=0af5b5c5-17f6-422e-b630-b28a279dd1e7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042221 Visual Abstract…
JAMAONCO_OF:04222021
JAMAONCO_OF:04152021
JAMAONCO_OF:04082021
JAMAONCO_OF:04012021
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 1, 2021 Media advisory: The full article and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0366?guestAccessKey=555e2943-4aa6-4726-bf66-459cbc8fbf9d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040121 Visual Abstract…